Literature DB >> 2828177

A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells.

M Petterson1, W Schaffner.   

Abstract

The enhancer of simian virus 40 (SV40) is active in a wide variety of tissues and hosts and thus has been called a general enhancer. Previous work has established that this region contains a number of subsegments, each with a different cell type specificity. By analyzing enhancer deletion mutants of SV40 with a restricted cell type specificity, we have identified a purine-rich DNA motif (Pu box) that is essential for activity of the mutant enhancer in lymphoid cells and also obtained evidence for an independent element that confers activity in kidney CV-1 cells. The Pu box element is positively regulated since binding of a cognate factor(s) was only observed in lymphoid cell extracts. The Pu box is also present in the 63-bp enhancer repeat of lymphotropic papovavirus (LPV), and competition experiments show that the SV40 and LPV sequences bind the same factor(s). Thus, the Pu box is likely to be a major determinant of the lymphotropic host range of LPV. In SV40, however, the Pu box is one of several enhancer elements with different cell specificities. We suggest that such an arrangement reflects a diversification strategy of SV40 to maximize its chance of adaptation to various types of host cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828177     DOI: 10.1101/gad.1.9.962

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  45 in total

1.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.

Authors:  Z Kozmik; S Wang; P Dörfler; B Adams; M Busslinger
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints.

Authors:  J G Judde; E E Max
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.

Authors:  D M Markovitz; M C Hannibal; M J Smith; R Cossman; G J Nabel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.

Authors:  C M Rudin; U Storb
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

6.  A novel cis-acting element, ESP, contributes to high-level endosperm-specific expression in an oat globulin promoter.

Authors:  Claudia E Vickers; Gangping Xue; Peter M Gresshoff
Journal:  Plant Mol Biol       Date:  2006-08-17       Impact factor: 4.076

7.  Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements.

Authors:  R N Pearse; R Feinman; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.

Authors:  S D Gitlin; R Bosselut; A Gégonne; J Ghysdael; J N Brady
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  A γ-hordein gene.

Authors:  V Cameron-Mills; A Brandt
Journal:  Plant Mol Biol       Date:  1988-07       Impact factor: 4.076

10.  Positive and negative regulation of immunoglobulin gene expression by a novel B-cell-specific enhancer element.

Authors:  J Wang; M Oketani; T Watanabe
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.